Cite
HARVARD Citation
Karantanos, T. et al. (2022). Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy. Leukemia & lymphoma. 63 (8), pp. 1942-1948. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Karantanos, T. et al. (2022). Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy. Leukemia & lymphoma. 63 (8), pp. 1942-1948. [Online].